Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
8.0
4.5
Journals
Cancers
Special Issues
Matrix Metalloproteinases in Cancer Progress
share announcement

Matrix Metalloproteinases in Cancer Progress

A special issue of Cancers (ISSN 2072-6694).

Deadline for manuscript submissions: closed (15 December 2013) | Viewed by 108943

Special Issue Editor

Prof. Dr. Constance E. Brinckerhoff

E-Mail Website
Guest Editor
Geisel School of Medicine at Dartmouth, Norris Cotton Cancer Center, Rubin 602, 1 Medical Center Drive, Lebanon, NH 03756, USA
Interests: melanoma, breast cancer, lung cancer, signal transduction, protease activated receptor-1 (par-1); angiogenesis, mmp-1, transcription, gene expression

Special Issue Information

Dear Colleagues,

The importance of MMPs in connective tissue remodeling and matrix degradation have been known for a long time. Increasingly, it is recognized that these enzymes have critical roles in signal transduction and gene regulation, and that they may have beneficial functions in normal homeostasis as well as in diseases. This special issue is dedicated to highlighting the more novel and innovative roles of secreted MMPs and their membrane bound counterparts, MT-MMPs, as mediators of cancer progression and as tumor suppressors. In addition, these enzymes may participate in cancers by functioning in organelles, such as exosomes and invadopodia. Thus, with their ubiquitous presence, they continue to represent attractive therapeutic targets and new strategies with improved efficacy are emerging. Finally, innovative models of cancers, such as zebrafish, may provide critical insights into how MMPs contribute to cancer progression.

Prof. Dr. Constance E. Brinckerhoff
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • novel roles of MMPs in tumor progression and suppression
  • gene regulation
  • signal transduction
  • model systems
  • organelles
  • therapeutic strategies

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (9 papers)

Download All Papers
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Review

710 KiB  
Review
Collagenolytic Matrix Metalloproteinases in Chronic Obstructive Lung Disease and Cancer
by Denzel Woode, Takayuki Shiomi and Jeanine D'Armiento
Cancers 2015, 7(1), 329-341; https://doi.org/10.3390/cancers7010329 - 5 Feb 2015
Cited by 8 | Viewed by 6796
Abstract
Chronic obstructive pulmonary disease (COPD) and lung cancer result in significant morbidity and mortality worldwide. In addition to the role of environmental smoke exposure in the development of both diseases, recent epidemiological studies suggests a connection between the development of COPD and lung [...] Read more.
Chronic obstructive pulmonary disease (COPD) and lung cancer result in significant morbidity and mortality worldwide. In addition to the role of environmental smoke exposure in the development of both diseases, recent epidemiological studies suggests a connection between the development of COPD and lung cancer. Furthermore, individuals with concomitant COPD and cancer have a poor prognosis when compared with individuals with lung cancer alone. The modulation of molecular pathways activated during emphysema likely lead to an increased susceptibility to lung tumor growth and metastasis. This review summarizes what is known in the literature examining the molecular pathways affecting matrix metalloproteinases (MMPs) in this process as well as external factors such as smoke exposure that have an impact on tumor growth and metastasis. Increased expression of MMPs provides a unifying link between lung cancer and COPD. Full article
(This article belongs to the Special Issue Matrix Metalloproteinases in Cancer Progress)
►▼ Show Figures

Figure 1

721 KiB  
Review
Roles of Matrix Metalloproteinases and Their Natural Inhibitors in Prostate Cancer Progression
by Yixuan Gong, Uma D. Chippada-Venkata and William K. Oh
Cancers 2014, 6(3), 1298-1327; https://doi.org/10.3390/cancers6031298 - 27 Jun 2014
Cited by 145 | Viewed by 16226
Abstract
Matrix metalloproteinases (MMPs), a group of zinc-dependent endopeptidases involved in the degradation of the extracellular matrix, play an important role in tissue remodeling associated with various physiological processes such as morphogenesis, angiogenesis, and tissue repair, as well as pathological processes including cirrhosis, arthritis [...] Read more.
Matrix metalloproteinases (MMPs), a group of zinc-dependent endopeptidases involved in the degradation of the extracellular matrix, play an important role in tissue remodeling associated with various physiological processes such as morphogenesis, angiogenesis, and tissue repair, as well as pathological processes including cirrhosis, arthritis and cancer. The MMPs are well established as mediators of tumor invasion and metastasis by breaking down connective tissue barriers. Although there has been a vast amount of literature on the role of MMPs in invasion, metastasis and angiogenesis of various cancers, the role of these endopeptidases in prostate cancer progression has not been systematically reviewed. This overview summarizes findings on the tissue and blood expression of MMPs, their function, regulation and prognostic implication in human prostate cancer, with a focus on MMP-2, -7, -9, MT1-MMP and tissue inhibitor of metalloproteinase 1 (TIMP-1). This review also summarizes the efficacy and failure of early-generation matrix metalloproteinase inhibitors (MMPIs) in the treatment of metastatic prostate cancer and highlights the lessons and challenges for next generation MMPIs. Full article
(This article belongs to the Special Issue Matrix Metalloproteinases in Cancer Progress)
1505 KiB  
Review
Fibrogenesis and Carcinogenesis in Nonalcoholic Steatohepatitis (NASH): Involvement of Matrix Metalloproteinases (MMPs) and Tissue Inhibitors of Metalloproteinase (TIMPs)
by Isao Okazaki, Takuji Noro, Nobuhiro Tsutsui, Eigoro Yamanouchi, Hajime Kuroda, Masayuki Nakano, Hiroaki Yokomori and Yutaka Inagaki
Cancers 2014, 6(3), 1220-1255; https://doi.org/10.3390/cancers6031220 - 27 Jun 2014
Cited by 41 | Viewed by 10189
Abstract
Nonalcoholic steatohepatitis (NASH) is emerging worldwide because life-styles have changed to include much over-eating and less physical activity. The clinical and pathophysiological features of NASH are very different from those of HBV- and HCV-chronic liver diseases. The prognosis of NASH is worse among [...] Read more.
Nonalcoholic steatohepatitis (NASH) is emerging worldwide because life-styles have changed to include much over-eating and less physical activity. The clinical and pathophysiological features of NASH are very different from those of HBV- and HCV-chronic liver diseases. The prognosis of NASH is worse among those with nonalcoholic fatty liver diseases (NAFLD), and some NASH patients show HCC with or without cirrhosis. In the present review we discuss fibrogenesis and the relationship between fibrosis and HCC occurrence in NASH to clarify the role of MMPs and TIMPs in both mechanisms. Previously we proposed MMP and TIMP expression in the multi-step occurrence of HCC from the literature based on viral-derived HCC. We introduce again these expressions during hepatocarcinogenesis and compare them to those in NASH-derived HCC, although the relationship with hepatic stem/progenitor cells (HPCs) invasion remains unknown. Signal transduction of MMPs and TIMPs is also discussed because it is valuable for the prevention and treatment of NASH and NASH-derived HCC. Full article
(This article belongs to the Special Issue Matrix Metalloproteinases in Cancer Progress)
►▼ Show Figures

Figure 1

691 KiB  
Review
Neutrophil Gelatinase-Associated Lipocalin (NGAL), Pro-Matrix Metalloproteinase-9 (pro-MMP-9) and Their Complex Pro-MMP-9/NGAL in Leukaemias
by Sandrine Bouchet and Brigitte Bauvois
Cancers 2014, 6(2), 796-812; https://doi.org/10.3390/cancers6020796 - 4 Apr 2014
Cited by 45 | Viewed by 12767
Abstract
Matrix metalloproteinase (MMP)-9 and neutrophil gelatinase-associated lipocalin (NGAL) have gained attention as cancer biomarkers. The inactive zymogen form of MMP-9 (pro-MMP-9) also exists as a disulphide-linked heterodimer bound to NGAL in humans. Leukaemias represent a heterogeneous group of neoplasms, which vary in their [...] Read more.
Matrix metalloproteinase (MMP)-9 and neutrophil gelatinase-associated lipocalin (NGAL) have gained attention as cancer biomarkers. The inactive zymogen form of MMP-9 (pro-MMP-9) also exists as a disulphide-linked heterodimer bound to NGAL in humans. Leukaemias represent a heterogeneous group of neoplasms, which vary in their clinical behavior and pathophysiology. In this review, we summarize the current literature on the expression profiles of pro-MMP-9 and NGAL as prognostic factors in leukaemias. We also report the expression of the pro-MMP-9/NGAL complex in these diseases. We discuss the roles of (pro)-MMP-9 (active and latent forms) and NGAL in tumour development, and evaluate the mechanisms by which pro-MMP-9/NGAL may influence the actions of (pro)-MMP-9 and NGAL in cancer. Emerging knowledge about the coexpression and the biology of (pro)-MMP-9, NGAL and their complex in cancer including leukaemia may improve treatment outcomes. Full article
(This article belongs to the Special Issue Matrix Metalloproteinases in Cancer Progress)
►▼ Show Figures

Graphical abstract

578 KiB  
Review
MicroRNAs in the Regulation of MMPs and Metastasis
by Mohammed Abba, Nitin Patil and Heike Allgayer
Cancers 2014, 6(2), 625-645; https://doi.org/10.3390/cancers6020625 - 25 Mar 2014
Cited by 60 | Viewed by 9910
Abstract
MicroRNAs are integral molecules in the regulation of numerous physiological cellular processes including cellular differentiation, proliferation, metabolism and apoptosis. Their function transcends normal physiology and extends into several pathological entities including cancer. The matrix metalloproteinases play pivotal roles, not only in tissue remodeling, [...] Read more.
MicroRNAs are integral molecules in the regulation of numerous physiological cellular processes including cellular differentiation, proliferation, metabolism and apoptosis. Their function transcends normal physiology and extends into several pathological entities including cancer. The matrix metalloproteinases play pivotal roles, not only in tissue remodeling, but also in several physiological and pathological processes, including those supporting cancer progression. Additionally, the contribution of active MMPs in metastatic spread and the establishment of secondary metastasis, via the targeting of several substrates, are also well established. This review focuses on the important miRNAs that have been found to impact cancer progression and metastasis through direct and indirect interactions with the matrix metalloproteinases. Full article
(This article belongs to the Special Issue Matrix Metalloproteinases in Cancer Progress)
►▼ Show Figures

Figure 1

1017 KiB  
Review
Monitoring and Inhibiting MT1-MMP during Cancer Initiation and Progression
by Sonia Pahwa, Maciej J. Stawikowski and Gregg B. Fields
Cancers 2014, 6(1), 416-435; https://doi.org/10.3390/cancers6010416 - 17 Feb 2014
Cited by 69 | Viewed by 11998
Abstract
Membrane-type 1 matrix metalloproteinase (MT1-MMP) is a zinc-dependent type-I transmembrane metalloproteinase involved in pericellular proteolysis, migration and invasion. Numerous substrates and binding partners have been identified for MT1-MMP, and its role in collagenolysis appears crucial for tumor invasion. However, development of MT1-MMP inhibitors [...] Read more.
Membrane-type 1 matrix metalloproteinase (MT1-MMP) is a zinc-dependent type-I transmembrane metalloproteinase involved in pericellular proteolysis, migration and invasion. Numerous substrates and binding partners have been identified for MT1-MMP, and its role in collagenolysis appears crucial for tumor invasion. However, development of MT1-MMP inhibitors must consider the substantial functions of MT1-MMP in normal physiology and disease prevention. The present review examines the plethora of MT1-MMP activities, how these activities relate to cancer initiation and progression, and how they can be monitored in real time. Examination of MT1-MMP activities and cell surface behaviors can set the stage for the development of unique, selective MT1-MMP inhibitors. Full article
(This article belongs to the Special Issue Matrix Metalloproteinases in Cancer Progress)
►▼ Show Figures

Figure 1

641 KiB  
Review
Matrix Metalloproteinases: The Gene Expression Signatures of Head and Neck Cancer Progression
by Shinji Iizuka, Naozumi Ishimaru and Yasusei Kudo
Cancers 2014, 6(1), 396-415; https://doi.org/10.3390/cancers6010396 - 13 Feb 2014
Cited by 39 | Viewed by 9276
Abstract
Extracellular matrix degradation by matrix metalloproteinases (MMPs) plays a pivotal role in cancer progression by promoting motility, invasion and angiogenesis. Studies have shown that MMP expression is increased in head and neck squamous cell carcinomas (HNSCCs), one of the most common cancers in [...] Read more.
Extracellular matrix degradation by matrix metalloproteinases (MMPs) plays a pivotal role in cancer progression by promoting motility, invasion and angiogenesis. Studies have shown that MMP expression is increased in head and neck squamous cell carcinomas (HNSCCs), one of the most common cancers in the world, and contributes to poor outcome. In this review, we examine the expression pattern of MMPs in HNSCC by microarray datasets and summarize the current knowledge of MMPs, specifically MMP-1, -3, -7 -10, -12, -13, 14 and -19, that are highly expressed in HNSCCs and involved cancer invasion and angiogenesis. Full article
(This article belongs to the Special Issue Matrix Metalloproteinases in Cancer Progress)
►▼ Show Figures

Figure 1

352 KiB  
Review
The Role of Matrix Metalloproteinases in Colorectal Cancer
by Anan H. Said, Jean-Pierre Raufman and Guofeng Xie
Cancers 2014, 6(1), 366-375; https://doi.org/10.3390/cancers6010366 - 10 Feb 2014
Cited by 181 | Viewed by 9685
Abstract
In the United States, colorectal cancer (CRC) is the third leading cause of cancer mortality, with limited treatment options for those with advanced disease. Matrix metalloproteinases (MMPs) are important for maintaining extracellular homeostasis but also play a prominent role in cancer cell invasion [...] Read more.
In the United States, colorectal cancer (CRC) is the third leading cause of cancer mortality, with limited treatment options for those with advanced disease. Matrix metalloproteinases (MMPs) are important for maintaining extracellular homeostasis but also play a prominent role in cancer cell invasion and dissemination. Expression levels of MMP-1, -2, -7, -9 and -13 correlate with worse outcomes; MMP-12 expression appears to be protective. Hence, MMPs are attractive therapeutic targets. Previous clinical trials using broad-spectrum MMP inhibitors were disappointing because of off-target toxicity and lack of efficacy. Now, the availability of safer, more selective inhibitors has renewed interest in therapeutic targeting of MMPs. Full article
(This article belongs to the Special Issue Matrix Metalloproteinases in Cancer Progress)
1198 KiB  
Review
Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression
by Antonietta Rosella Farina and Andrew Reay Mackay
Cancers 2014, 6(1), 240-296; https://doi.org/10.3390/cancers6010240 - 27 Jan 2014
Cited by 163 | Viewed by 20748
Abstract
Since its original identification as a leukocyte gelatinase/type V collagenase and tumour type IV collagenase, gelatinase B/matrix metalloproteinase (MMP)-9 is now recognised as playing a central role in many aspects of tumour progression. In this review, we relate current concepts concerning the many [...] Read more.
Since its original identification as a leukocyte gelatinase/type V collagenase and tumour type IV collagenase, gelatinase B/matrix metalloproteinase (MMP)-9 is now recognised as playing a central role in many aspects of tumour progression. In this review, we relate current concepts concerning the many ways in which gelatinase B/MMP-9 influences tumour biology. Following a brief outline of the gelatinase B/MMP-9 gene and protein, we analyse the role(s) of gelatinase B/MMP-9 in different phases of the tumorigenic process, and compare the importance of gelatinase B/MMP-9 source in the carcinogenic process. What becomes apparent is the importance of inflammatory cell-derived gelatinase B/MMP-9 in tumour promotion, early progression and triggering of the “angiogenic switch”, the integral relationship between inflammatory, stromal and tumour components with respect to gelatinase B/MMP-9 production and activation, and the fundamental role for gelatinase B/MMP-9 in the formation and maintenance of tumour stem cell and metastatic niches. It is also apparent that gelatinase B/MMP-9 plays important tumour suppressing functions, producing endogenous angiogenesis inhibitors, promoting inflammatory anti-tumour activity, and inducing apoptosis. The fundamental roles of gelatinase B/MMP-9 in cancer biology underpins the need for specific therapeutic inhibitors of gelatinase B/MMP-9 function, the use of which must take into account and substitute for tumour-suppressing gelatinase B/MMP-9 activity and also limit inhibition of physiological gelatinase B/MMP-9 function. Full article
(This article belongs to the Special Issue Matrix Metalloproteinases in Cancer Progress)
►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-9
Back to TopTop